Biobusiness Development Grants Awarded

Biobusiness grants help develop Minnesota businesses and infrastructure to deliver regenerative medicine products and services. Learn more about how to apply for a biobusiness grant by reading our frequently asked questions

 

View bio business grants awarded by year.
Frank H. Burton, PhD
This project is performing translational studies on a wound-healing accelerant that has been provisionally patented. Animal studies showed that…
2019-2020
Vanesa Alonso-Camino, PhD
We plan to isolate and expand glioblastoma (GBM) cells from commercially available fresh tumor tissue. These cells will be used to create tumor…
2019-2020
Timothy D. O'Brien, DVM, PhD
Our overall goal is to develop a cell therapy product for the treatment of Parkinson's disease.  In the present proposal we will evaluate critical…
2018-2019
Joseph S. Uzarski, PhD
Miromatrix is working to create a new source of kidney grafts for thousands of patients suffering from kidney failure who are wait-listed for…
2018-2019
Zachary Resch, PhD
The Mayo Clinic CRM Biotrust has the role of escalating promising cellular and acellular biologics from bench to clinical-grade products, through…
2018-2019
James R. Dutton, PhD
Funding to equip laboratory space at the UMN Stem Cell Institute to provide a shared-space Innovation and Prototype Facility to support start-up…
2018-2019
Alicia Wallis, PhD
Equipment for CD34 cell isolation and selection in our planned cGMP operation for regenerative medicine.
2018-2019
Satsuki Yamada, MD, PhD
This proposal aims to establish the state‐of‐the‐art ultrasound platform armed with photoacoustic technology specialized for regenerative therapies…
2018-2019
James R. Thompson, PhD
The goal of this project is to prove that commercial production of regenerative proteins can be made consistently and with a significant cost…
2018-2019
James Thompson, PhD
After completing "proof of concept" experiments that produced human proteins in tobacco plants and acquiring a new lab facility, we seek to upscale…
2017-2018
John Schorgl, BA
Peytant Solutions is developing a human amnion tissue cover scaffold, called the AmnioStent™, for the treatment of malignant airway strictures. …
2017-2018
Walter C. Low, PhD
The goal of this project is to produce authentic human dopamine neurons that can be used for cell transplantation therapy for patients with…
2017-2018